Two Sigma Advisers
KRRO icon

Two Sigma Advisers’s Korro Bio KRRO Stock Holding History

Two Sigma Advisers’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,237
Closed -$90K – 1145
2025
Q4 		$90K Sell
11,237
-172
-2% -$4.02K ﹤0.01% 2239
2025
Q3 		$546K Buy
+11,409
New +$253K ﹤0.01% 1729
2023
Q4 		– Sell
-204
Closed -$3.77K – 2576
2023
Q3 		$3.77K Buy
+204
New +$5.12K ﹤0.01% 2359
2022
Q2 		– Sell
-490
Closed -$52K – 2779
2022
Q1 		$52K Sell
490
-1,476
-75% -$282K ﹤0.01% 2586
2021
Q4 		$504K Sell
1,966
-1,678
-46% -$510K ﹤0.01% 1905
2021
Q3 		$1.29M Buy
3,644
+362
+11% +$142K ﹤0.01% 1494
2021
Q2 		$1.63M Buy
+3,282
New +$1.6M ﹤0.01% 1399

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Two Sigma Advisers's KRRO Position: Q1 2026 in Review

Two Sigma Advisers sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 11,237 shares — an estimated $90K sold.

Two Sigma Advisers first reported a position in KRRO in Q2 2021 and held it in 7 quarters. The position peaked at $1.63M in Q2 2021. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Two Sigma Advisers reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 11,237 Korro Bio shares in Q1 2026, an estimated $90K.
  • Two Sigma Advisers first reported a position in Korro Bio in Q2 2021 and held it in 7 quarters.
  • Two Sigma Advisers's Korro Bio position peaked at $1.63M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.